Blood Pressure Lowering Effects of Amosartan Regarding Proviso iN Patients With High Blood Pressure

Completed

• Conditions: Hypertension

• Registration Number: NCT03255551
• Lead Sponsor: Seoul National University Bundang Hospital

Brief Summary

Blood Pressure Lowering Effects of Amosartan Regarding Proviso in Patients with Hypertension

Detailed Description

After taking Amozatan (AMS, amlodipine / rozanthin combination) in patients with essential hypertension, the percentage of patients who reached the mean systolic target blood pressure was evaluated

Study Timeline

• Study Start: 2014-01-01
• Primary Completion: 2015-06-30
• Study Completion: 2015-12-31
• Status Verified: 2017-08
• Study First Submitted: 2017-08-16
• Study First Submitted QC: 2017-08-16
• Last Update Submitted: 2017-08-16
• Study First Posted: 2017-08-21
• Last Update Posted: 2017-08-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Patients with essential hypertension whose blood pressure is not adequately controlled by amlodipine or rosartan monotherapy
• In patients with stage 2 hypertension (SBP 160-179 mmHg), patients requiring a combination therapy to reach the target blood pressure
• Patients who were changed to amosartan while using other hypertensive agents

Exclusion Criteria

• Patients with hypersensitivity to dihydropyridine derivatives of amosartan
• Women who are pregnant or who may be pregnant and breastfeeding
• Patients with severe hepatic dysfunction
• Patients with severe aortic stenosis
• Patients at risk of shock
• Patients participating in other clinical studies

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patients with essential hypertension evaluated the mean blood pressure after taking amosartan.	6 month	Blood Pressure Lowering Effects of Amosartan Regarding Proviso in Patients with Hypertension